3. Summary
Global Markets Direct’s, Cognitive Disorders - Pipeline Review, H2 2012,
provides an overview of the indication’s therapeutic pipeline. This report
provides information on the therapeutic development for Cognitive Disorders,
complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Cognitive Disorders. Cognitive Disorders - Pipeline Review, Half
Year is built using data and information sourced from Global Markets Direct’s
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s
team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
4. Scope
- A snapshot of the global therapeutic scenario for Cognitive Disorders.
- A review of the Cognitive Disorders products under development by companies
and universities/research institutes based on information derived from company
and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Cognitive Disorders.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
5. Table Of Contents
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Cognitive Disorders Overview 11
Therapeutics Development 12
An Overview of Pipeline Products for Cognitive Disorders 12
Cognitive Disorders Therapeutics under Development by Companies 14
Cognitive Disorders Therapeutics under Investigation by
Universities/Institutes 20
Late Stage Products 24
Comparative Analysis 24
Mid Clinical Stage Products 25
Comparative Analysis 25
Early Clinical Stage Products 26……………………………
7. For More details about above & other Reports
plz contact :
Lavanya
Aarkstore.com
Contact: Marketing team
Mob.No.918149852585
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore